Hemostatic Profiles of Patients Who Underwent Transcatheter Versus Surgical Aortic Valve Replacement Versus Percutaneous Coronary Intervention

Written By CCRG CCRG Admin

Jonathon Paul Fanning, Shaun Roberts, Chris Anstey, Stephanie Yerkovich, Lawrence Yanxi Lu, Karl Poon, Alexander Incani, Sarvesh Natani, James McCullough, James Winearls, John Francis Fraser. American Journal of Cardiology. DOI https://doi.org/10.1016/j.amjcard.2023.08.100

Highlights:

  • Transcatheter aortic valve replacement is associated with a tendency to form blood clots during the operation.

  • The differences in coagulation profiles between transcatheter aortic valve replacement and percutaneous coronary intervention cannot be solely attributed to variations in heparin dosages.

  • Viscoelastic hemostatic assays are useful tools for intraoperative monitoring of hemostasis, but parameters from different device are not interchangeable.

CCRG CCRG Admin
Previous

Creating the ICU of the Future: Patient-centred design to optimise recovery.
Next

Characteristics and outcomes of patients with severe COVID-19 in Indonesia: Lessons from the first wave